{"id":"W2133649359","doi":"10.1002/ana.23908","title":"Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β‐amyloid","year":2013,"lang":"en","type":"article","venue":"Annals of Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":413,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute on Aging; Canadian Institutes of Health Research","keywords":"Cerebrospinal fluid; Positron emission tomography; Neuroimaging; Dementia; Alzheimer's Disease Neuroimaging Initiative; Alzheimer's disease; Pathology; Internal medicine; Pittsburgh compound B; Medicine; Biomarker; Amyloid (mycology); Psychology; Longitudinal study; Nuclear medicine; Disease; Neuroscience; Chemistry","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06726373935474916,"score_gpt":0.3398819343178093,"score_spread":0.2726181949630601,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}